# GMED — Globus Medical · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** GMED  
**Sources:** 27  
**Published:** 2026-09-25  
**Canonical:** https://app.k3vl4r.com/research/deep-research-gmed-globus-medical-catalysts-narrative-risks-4775

---

# Globus Medical (NYSE: GMED) — As of 2026-09-25

*Background context (unverified): NYSE-listed, Healthcare/Medical Devices, market cap ~$9.93B (2026-09-23), headquartered in Audubon, Pennsylvania [background], [[28]](https://finance.yahoo.com/quote/GMED/).*

## Recent Catalysts (last ~1–3 months)

The dominant near-term catalyst was the **Q2 2026 earnings release on August 6, 2026** (after market close, followed by a 4:30 p.m. ET teleconference) [[2]](https://www.quiverquant.com/news/GLOBUS+MEDICAL+%28%24GMED%29+Releases+Q2+2026+Earnings%2C+Stock+Rises), [[5]](https://simplywall.st/stocks/us/healthcare/nyse-gmed/globus-medical/news/globus-medical-gmed-stock-leans-on-margin-gains-as-nevro-rec), [[6]](https://www.quiverquant.com/news/Globus+Medical+to+Announce+Second+Quarter+2026+Financial+Results+on+August+6). Reported results:

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-gmed-globus-medical-catalysts-narrative-risks-4775 (free to sign up)._